The BRIGHT CP Meta-Study: Accelerating the Path to a Functional Cure
The BRIGHT Cerebral Palsy Cure Project is bridging the gap between clinical research and real-world recovery through our comprehensive CP Meta-Study. This live repository aggregates and synthesizes global breakthroughs across ten critical domains—including brain biology, digital signal processing, and cellular metabolic fueling.
Why Our Research Matters
Unlike static databases, our NeuroLoop Protocol provides a dynamic analysis of the latest data from NCBI PubMed and Entrez databases. We don’t just collect studies; we evaluate their impact as Additive, Supportive, or Legacy, ensuring that “Additive” breakthroughs—such as our recent discovery regarding active cellular scars and fibrosis unlocking—are immediately integrated into actionable neuro-rehabilitation frameworks.
Rooted in Expertise and Integrity
Founded by Matt Palaszynski, a GE alumnus with 25+ years of lived experience navigating CP care, BRIGHT combines professional systems-thinking with deep personal advocacy. Supported by a Scientific Advisory Board of world-renowned PhDs and MDs, our 501(c)(3) non-profit remains strictly independent, maintaining no commercial interests in the technologies or pharmaceuticals we review.
If you are a medical professional looking to gain access to our database, please contact us at donations@brightfoundation.org.
Founder, BRIGHT Foundation: Leading a global initiative to “close the loop” on Cerebral Palsy recovery through data-driven research.
25+ Years Lived Experience: Navigating life with a daughter with CP provides a primary, first-person understanding of the physiological and clinical gaps in current care models.
GE Alumnus & Business Leader: Leveraging decades of experience in operational excellence, complex systems, and strategic leadership to apply rigorous meta-study frameworks to neurological research.
Methodology: Combines personal advocacy with professional systems-thinking to synthesize NCBI PubMed data into the actionable NeuroLoop Protocol.
Conflict of Interest Statement
The BRIGHT Foundation and its founder, Matt Palaszynski, maintain no commercial or business interests in the medical technologies, pharmaceutical products, or clinical services discussed on this page.
Non-Profit Mission: Our objective is purely research-driven, aimed at identifying the most effective paths to a functional cure.
Independence: No funding is received from manufacturers of the devices or therapies reviewed in our weekly meta-studies.
Transparency: All citations are linked directly to PubMed (PMIDs) to ensure users can verify the raw data independently.
Leave a Reply
About BRIGHT
BRIGHT was founded in 2002 and is a 501(c)(3) non-profit who’s mission is to provide support and information for families who’s children have suffered a Brain Injury which often leads to Cerebral Palsy. BRIGHT’s goal is to fund research leading to a cure.